Mar 13, 2008 - ProEthic Pharmaceuticals, Inc. today announced the launch of Ibudone(TM) (hydrocodone bitartrate and ibuprofen tablets), a new prescription fixed combination of hydrocodone and ibuprofen for the short-term (generally less than 10 days) management of acute pain.
Ibudone provides the highest hydrocodone/ibuprofen dosage available - 10 mg of hydrocodone/ 200 mg of ibuprofen - in each tablet. Peak plasma levels are achieved in less than two hours. Ibudone is also available with 5 mg hydrocodone/ 200 mg of ibuprofen.
Carl Whatley, Chairman and CEO of ProEthic Pharmaceuticals, stated, "By combining 10 mg of hydrocodone with the gold standard NSAID, ibuprofen, Ibudone offers a powerful new option for relieving acute pain. It is important to note that Ibudone does not have the risk of acetaminophen liver toxicity, a leading cause of acute liver failure in the United States. In addition, Ibudone also offers physicians Schedule III prescribing convenience, a key issue with today's busy practices."
ProEthic acquired the exclusive marketing, sales and distribution rights to Ibudone from Vintage Pharmaceuticals (Huntsville, Alabama). To learn more about Ibudone, visit www.ibudone.com.
No comments:
Post a Comment